| This week's sponsor is ExL Events. | | | |
| Welcome to FierceLifeSci Weekly Digest, your roundup of the biggest and most popular stories from each of our publications. | |
|
Featured Story | | | Tuesday, October 9, 2018 Novartis is set to open innovation labs around the world to connect with tech companies. The labs, the first of which has opened in San Francisco, will serve as a bridge between companies developing R&D-enhancing technologies and the broader Novartis business. |
|
|
| This week's sponsor is Medidata. | | | Delivering a patient-centric approach
We believe that every single trial is an opportunity to empower patients with technology. Hear from subject matter experts on how using eCOA is improving patient engagement and delivering real-time insights.
Watch Now. |
Top Stories Of The Week Friday, October 5, 2018 GlaxoSmithKline has decided to keep its cephalosporin antibiotics business but reorganize it to be more efficient, cutting nearly 200 jobs at its Ulverston site in the U.K. Monday, October 8, 2018 The FDA has cleared a direct-to-consumer hearing aid, developed by speaker manufacturer Bose, potentially opening the door for other consumer-focused electronics companies. Tuesday, October 9, 2018 Some new CEOs fill out their executive team roster over time as leaders from the previous regime make their exits. Not Pfizer’s. On Tuesday, the New York company unveiled the list of executives that will support incoming chief Albert Bourla when he takes the baton from retiring Ian Read on Jan. 1. Monday, October 8, 2018 Last week, Eli Lilly unveiled positive data for a new diabetes drug with serious potential to disrupt the GLP-1 market. But its rivals don't need to hunker down, analysts said. Tuesday, October 9, 2018 Affimed has halted work on two phase 1 trials of its lead T cell engager AFM11 for blood cancers after a death and two life-threatening events. Monday, October 8, 2018 Merck's Remicade biosimilar hasn't made much of a splash on the market, but the company won a national contract with the Department of Veterans Affairs due to a pricing offer that beat out rivals. Monday, October 8, 2018 Spark Therapeutics announced encouraging preclinical data on SPK-3006, its investigational gene therapy to treat Pompe disease. The inherited lysosomal storage disease causes the sugar glycogen to build up in muscles and organs such as the heart, impairing their function. Monday, October 8, 2018 With HPV vaccine uptake slow to take off in the U.S. way back when, Merck & Co.'s Gardasil shots missed out on many eligible patients. But now, Merck has another chance—and so do the men and women who didn't get their shots the first time around. Wednesday, October 10, 2018 Takeda biotech spinoff GenAhead Bio has inked a nonexclusive license deal to access ERS Genomics’ CRISPR/Cas9 patents for genome editing technology. | This week's sponsor is Biotech Primer. | | | |
Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: SAP Collaborate in a digital world to improve patient outcomes. Sponsored by: Veeva Industry Research: Read the 2018 Unified Clinical Operations Report to find out how pharmas and CROs are evolving clinical trial processes. Sponsored by: Patheon, part of Thermo Fisher Scientific Read this whitepaper to learn more about two main areas where a drug developer can face significant obstacles during biologics development. Sponsored by: RWS Life Sciences Examine the linguistic and cultural considerations of global eCOA and BYOD. Sponsored by: Amazon Web Services Download our new eBook to learn how Healthcare and Life Sciences organizations are taking advantage of solutions from AWS and the AWS Partner Network to obtain value from critical data. Sponsored by: Covance FSPx Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries. Sponsored by: Covance FSPx Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries. Sponsored by: Reprints Desk, Inc. Go from Search to Full-Text Scientific Papers in a Single Click! Sponsored by: Veeva A top 20 pharma and growing biotech re-engineer regulatory processes. Sponsored by: Sciformix Are automation, big data and artificial intelligence (AI) a key part of your company’s pharmacovigilance strategy? Read this whitepaper to know what they should be! Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. Sponsored by: Catalent Develop a basic understanding of principles and concepts of bioavailability of oral drugs. | 